Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
11,034
-47
-0.4% -$1.67K 0.11% 202
2026
Q1
$332K Sell
11,081
-55
-0.5% -$1.75K 0.07% 276
2025
Q4
$325K Buy
11,136
+389
+4% +$10.3K 0.07% 291
2025
Q3
$281K Sell
10,747
-666
-6% -$16.5K 0.08% 301
2025
Q2
$257K Sell
11,413
-109
-0.9% -$2.24K 0.06% 353
2025
Q1
$241K Sell
11,522
-638
-5% -$13.4K 0.08% 306
2024
Q4
$258K Sell
12,160
-280
-2% -$6.13K 0.08% 291
2024
Q3
$289K Buy
+12,440
New +$292K 0.09% 285

Other funds holding IX

Net Worth Advisory Group's IX Position: Q2 2026 in Review

Net Worth Advisory Group reduced its ORIX (IX) stake by 0.42% in Q2 2026, selling an estimated $1.67K and leaving 11,034 shares worth $420K. The position accounts for 0.11% of the portfolio, ranked #202.

Net Worth Advisory Group first reported a position in IX in Q3 2024 and has held it in 8 quarters since. 40 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Net Worth Advisory Group held 11,034 shares of ORIX worth $420K as of Q2 2026.
  • Net Worth Advisory Group sold 47 ORIX shares in Q2 2026, an estimated $1.67K.
  • ORIX made up 0.11% of Net Worth Advisory Group's portfolio in Q2 2026, its #202 holding.
  • Net Worth Advisory Group first reported a position in ORIX in Q3 2024 and has held it in 8 quarters since.
  • 40 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.